PBH Stock Forecast & Price Target

Prestige Consumer is well-positioned for long-term success with its diverse portfolio of leading brands and strong recommendations from medical professionals. The recent divestiture of Shaw Bakers and potential divestiture of the PFD segment will help the company further delever and potentially lead to a re-rating of its multiple. The company's increased EBITDA estimates and strong exposure to the US market also adds to its positive outlook, although there are potential risks in underwhelming guidance or an increase in beef inflation.

Prestige Consumer is facing several challenges such as rising input costs, tariffs, and consumers' reluctance to spend on higher-priced items. While the company's investments in internal growth may provide good returns, it is still mired in a capex investment cycle that has resulted in higher costs for key commodities. Additionally, its recent divestment of non-core assets may result in deleveraging, but the company's ability to hit its EBITDA target is uncertain, and broader inflation concerns could also impact its performance. Finally, Premium Brands Holdings Corporation, which Prestige owns a 50% stake in, is facing challenges as well, which could further impact Prestige's performance.